Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Ravi Anand, MD
JCP
Original Research
BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study
September 15, 2012
Yona Geffen
,
Richard Keefe
,
Jonathan Rabinowitz
, et al
JCP
Academic Highlights
Alzheimer's Disease: Translating Neurochemical Insights Into Clinical Benefits
October 31, 2000
Changiz Geula
,
Martin Farlow
,
Jeffrey Cummings
, et al
JCP
Academic Highlights
New Insights Into Genetics and Pathophysiology of Alzheimer's Disease: What Are the Clinical and Therapeutic Implications?
September 30, 2000
Michael Mullan
,
George Grossberg
,
Ravi Anand
, et al
PCC
Original Research
Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening
August 1, 2000
Murray Raskind
,
Vinod Kumar
,
Lisa Malaty
, et al
JCP
Article
Clozapine: The Commitment to Patient Safety
December 1, 1999
Larry D. Alphs
,
Ravi Anand
